Welcome to our dedicated page for Oklo SEC filings (Ticker: OKLO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Oklo Inc. (OKLO) SEC filings document the regulatory record of an advanced nuclear technology company developing fast fission power plants, nuclear fuel recycling and critical isotope supply. For Oklo, quarterly reports and amended quarterly reports are useful for reviewing operating updates, capital-structure disclosure, risk factors and the company’s description of its nuclear development activities.
Oklo’s Form 8-K filings are especially relevant because the company’s business can be affected by material agreements, financing arrangements, officer and director changes, shareholder voting results and other reported events. Recent 8-K categories include material definitive agreements, governance matters and annual meeting results. These filings help investors separate company-disclosed events from general market commentary about advanced nuclear power.
Annual reports, quarterly reports and proxy statements can also show how Oklo explains its business model, emerging growth company status, governance structure, executive compensation framework and stockholder voting matters. The company’s proxy materials and meeting-result filings provide details on board elections, auditor ratification and other shareholder matters.
For OKLO stock research, the most relevant filing types include Form 10-K for annual business and risk disclosure, Form 10-Q for quarterly updates, Form 8-K for material events, and DEF 14A proxy statements for governance and compensation information. These documents are central to understanding Oklo’s public-company obligations as it works on Aurora powerhouse commercialization, fuel recycling and isotope-related projects.
Oklo Inc. Chief Financial Officer Richard Craig Bealmear exercised stock options and sold shares. On 2026-03-02, he exercised 16257.0000 stock options, receiving 16257.0000 shares of Class A Common Stock at 3.1800 per share, then sold 16257.0000 shares at 60.0000 per share in an open-market transaction under a Rule 10b5-1 plan adopted on September 22, 2025. Following these transactions, he held 294255.0000 Class A shares and 852434.0000 options, and the option’s expiration date is clarified as December 22, 2033.
Oklo, Inc. filed a Form 144 disclosing a proposed sale of 16,257 Class A shares on 03/02/2026, sourced from options granted 12/23/2023 and to be sold for cash.
The filing also lists recent sales by Richard C. Bealmear of 69,841 shares on 12/17/2025 for $5,460,930.65, 5,159 shares on 12/18/2025 for $397,088.23, and 9,726 shares on 02/02/2026 for $748,216.32.
Oklo Inc.’s Chief Financial Officer Richard Craig Bealmear reported multiple equity transactions in early February 2026. On February 2 and 3, he exercised stock options for 9,726 and 97,342 shares of Class A common stock at an exercise price of $3.18 per share. On February 2, he sold 9,726 Class A shares at a weighted average price of $76.9295 per share under a Rule 10b5-1 trading plan adopted on September 22, 2025. Following these transactions, he directly held 196,913 Class A common shares and 868,691 stock options, which began vesting on August 1, 2024 and continue to vest in monthly installments.
Oklo Inc. director, CEO, and 10% owner Jacob DeWitte reported multiple insider sales of Class A common stock on February 2, 2026. The Form 4 shows direct sales, including 16,181 shares at $73.8095 and 43,819 shares at $74.6863, plus additional sales through a grantor retained annuity trust in his name.
The filing also lists large indirect holdings in family trusts and GRATs associated with DeWitte and his spouse Caroline Cochran, some of which executed similar same‑day sales. All sales were made under a pre‑established Rule 10b5-1 trading plan adopted on March 31, 2025.
Oklo Inc. director, co-founder and COO Caroline Cochran reported multiple planned insider stock sales in Oklo Class A common shares. The transactions on February 2, 2026 were executed under a Rule 10b5-1 trading plan adopted on March 31, 2025.
Cochran reported direct sales of 16,181 shares at a weighted average price of $73.8095 and 43,819 shares at $74.6863. Additional sales were reported from entities associated with her and her spouse, including GRATs and family trusts, while substantial indirect holdings remain reported after the transactions.
Oklo insider Richard C. Bealmear has filed a notice to sell 9,726 Class A shares, with an aggregate market value of 748,216.60, through Fidelity Brokerage Services on or about 02/02/2026 on the NYSE. These shares were acquired the same day by exercising options granted on 12/23/2023 for cash.
In the past three months, Bealmear also sold 69,841 Class A shares on 12/17/2025 for gross proceeds of 5,460,930.65 and 5,159 Class A shares on 12/18/2025 for gross proceeds of 397,088.23. The filing lists 156,247,075 Class A shares outstanding.
BlackRock, Inc. filed an amended ownership report showing it beneficially owns 14,419,350 shares of Oklo Inc Class A stock, representing 9.2% of the class as of the reporting date. BlackRock reports sole voting power over 14,008,793 shares and sole dispositive power over the full 14,419,350 shares, with no shared voting or dispositive authority.
The filing explains that these holdings are aggregated across certain BlackRock business units and are held in the ordinary course of business. Various underlying clients have rights to dividends or sale proceeds, but no single client has more than five percent of Oklo’s outstanding common shares. BlackRock certifies that the position is not held for the purpose of changing or influencing control of Oklo.
Oklo Inc. director, Co-Founder and COO Caroline Cochran, a 10% owner, reported multiple insider sales of Class A Common Stock. On January 9, 2026, she sold 26,741 shares at a weighted average price of $111.38 per share, leaving 799,023 shares held directly. Related entities, including a Caroline Cochran GRAT, sold 12,977 shares at a weighted average of $112.32 and 6,096 shares at $112.83.
The filing also lists significant indirect holdings through family trusts and GRATs associated with Cochran’s spouse, including 7,583,085 shares held by the Caroline DeWitte Family Trust and 7,851,901 shares held by the Jacob DeWitte Family Trust as of January 9, 2026. All reported sales were effected under a Rule 10b5-1 trading plan adopted on March 31, 2025, indicating these transactions were pre-arranged rather than discretionary trades.
Oklo Inc. CEO, Co‑Founder and director Jacob DeWitte, a 10% owner, reported multiple open‑market sales of Class A common stock on January 9, 2026 under a pre‑arranged Rule 10b5‑1 trading plan adopted on March 31, 2025.
The transactions included 26,740 shares sold directly at a weighted average price of $111.38, plus 12,977 shares and 6,097 shares sold at weighted average prices of $112.32 and $112.83, respectively, through a Jacob DeWitte GRAT. Additional same‑day sales of 26,741, 12,977 and 6,096 shares at the same respective weighted average prices were reported as indirect holdings through DeWitte’s spouse and related GRATs.
Following these trades, DeWitte reports beneficial ownership of 808,197 shares held directly, along with large indirect positions through a GRAT, family trusts and additional GRAT structures for himself and his spouse.
Oklo Inc. director and Co-Founder/COO Caroline Cochran reported multiple sales of Class A common stock on January 7 and 8, 2026, made under a pre-arranged Rule 10b5-1 trading plan adopted on March 31, 2025. The Form 4 shows a series of open-market sales at weighted average prices ranging from about $93.79 to about $100.06 per share, including transactions such as 34,579 shares sold at a weighted average price of $97.9189 and 35,499 shares at $98.7542 in direct holdings.
After the reported trades, Cochran directly held 827,019 Oklo Class A shares, with additional indirect holdings through a GRAT that held 1,410,173 shares, and large blocks held through family trusts and GRATs associated with her spouse, Jacob DeWitte, including 7,583,085 shares in the Caroline DeWitte Family Trust and 7,851,901 shares in the Jacob DeWitte Family Trust.